Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 4, 2021

View Archived Issues

China's NMPA accepts Kintor's IND for topical AR degrader GT-20029

FDA authorizes initiation of pivotal phase III study of NE-3107 in AD

A bivalent measles-based COVID-19 vaccine shows antiviral efficacy in vivo and Th1-biased responses

Multivalent nanobodies potently neutralize SARS-CoV-2 and prevent mutational escape

Positive topline data from phase II study of Allocetra in severe and critical COVID-19

Crinetics initiates phase I study of CRN-04777

Preliminary phase I data show safety and immunogenicity of VXA-CoV2-1 oral tablet vaccine

New cannabinoid CB1 and CB2 receptor ligands identified at Canopy Growth Corp.

Cybrexa 3 patents peptide conjugates of microtubule-targeting agents

Novartis discovers AKR1C3-dependent GTPase KRAS inhibitors

California Institute of Technology, Rockefeller University describe anti-HIV vaccine antibodies

Phase Ib data show lack of objective response for CMP-001 plus atezolizumab in NSCLC

RCC-33 reduces tumor volume in mice inoculated with colorectal cancer cells

ABTL-0812 plus paclitaxel and carboplatin result in increased efficacy in NSCLC

ViaCyte begins phase II study of VC01-103 in type 1 diabetes

JADE family of markers has prognostic value in NSCLC

New dengue virus inhibitor shows preclinical promise

CRY1 protein activators allow circadian clock manipulation with light

Roche discloses new monoglyceride lipase inhibitors

Erlotinib plus anlotinib shows promise in EGFR-mutated NSCLC

FDA grants accelerated approval to Tepmetko for metastatic NSCLC with METex14 skipping alterations

Daiichi Sankyo initiates phase II study of patritumab deruxtecan in EGFR-mutated NSCLC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...